Agricultural biologicals have entered a new technology race, with RNA-based crop protection and biocontrol platforms drawing investment and regulatory attention from the United States to Brazil, AgroLatam reports.

The report frames the two countries as the principal arenas where the next generation of biological inputs will be developed, tested and commercialized. For growers, the stakes are input costs: biologicals positioned as alternatives or complements to synthetic chemistry directly affect per-acre pesticide budgets and resistance-management programs.

What is driving the race?

RNA-based pesticides — products that silence target genes in pests rather than poisoning them chemically — represent the most closely watched category. Biocontrol agents, including microbial and biochemical products, form the broader field in which the competition is unfolding.

The geographic framing matters for trade and supply. Brazil is one of the world's largest markets for crop protection, and its tropical pest pressures make it a natural testing ground for biological platforms. U.S. developers, backed by agtech investment, are pushing the same technologies toward row-crop and specialty applications.

Why should growers and input buyers care?

• Biologicals increasingly sit alongside synthetic chemistry in integrated pest management programs.
• RNA platforms promise species-specific action, which could reshape resistance management.
• Competition between U.S. and Brazilian developers may accelerate regulatory review and market entry timelines.

AgroLatam does not publish specific investment figures, registration dates or yield outcomes in the referenced report, so the story remains at the level of market structure rather than verified commercial results.

What comes next?

The race is expected to intensify as developers on both sides move products from trials toward registration, with Brazil's regulatory pathway and U.S. commercial launch timelines the benchmarks to watch.